NRSNVSORMP• 28 Days (Normalized)
NRSN vs ORMP (NeuroSense Therapeutics Ltd. vs Oramed Pharmaceuticals Inc.)
Showing Closing Date Range from Sep 11 to Oct 9, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
NRSN Performance $3.66
+954.76%
NeuroSense Therapeutics Ltd.
Normalized Baseline0.00%
ORMP Performance $4.33
-7.08%
Oramed Pharmaceuticals Inc.
Normalized Baseline0.00%
Alpha Spread Margin NRSN LEADS
+961.84 pts
NRSN outperforming by 961.84 percentage points
NRSNORMP
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
NRSN ORMP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(21 dates)
| Date | NRSN Price | NRSN Gain (%) | ORMP Price | ORMP Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 09, 2026 | $3.66 | +954.76% | $4.33 | -7.08% | +961.84% |
| Oct 08, 2026 | $3.58 | +931.70% | $4.20 | -9.87% | +941.57% |
| Oct 07, 2026 | $3.82 | +1000.86% | $4.37 | -6.22% | +1007.08% |
| Oct 06, 2026 | $4.07 | +1072.91% | $4.38 | -6.01% | +1078.92% |
| Oct 05, 2026 | $4.03 | +1061.38% | $4.55 | -2.36% | +1063.74% |
| Oct 02, 2026 | $3.94 | +1034.01% | $4.49 | -3.65% | +1037.66% |
| Oct 01, 2026 | $- | $4.48 | -3.86% | - | |
| Sep 30, 2026 | $- | $4.67 | +0.21% | - | |
| Sep 29, 2026 | $4.78 | +1277.52% | $4.69 | +0.64% | +1276.88% |
| Sep 28, 2026 | $5.10 | +1369.74% | $4.75 | +1.93% | +1367.81% |
| Sep 25, 2026 | $6.95 | +1902.88% | $- | - | |
| Sep 24, 2026 | $7.40 | +2032.56% | $- | - | |
| Sep 23, 2026 | $7.40 | +2032.56% | $4.72 | +1.29% | +2031.27% |
| Sep 22, 2026 | $7.18 | +1969.16% | $- | - | |
| Sep 21, 2026 | $6.62 | +1807.78% | $4.70 | +0.86% | +1806.92% |
Page 1 of 2